seed
Stage
2018
Founded
1
Investors
About
Achieve Life Sciences is a specialty pharmaceutical company focused on addressing the global smoking health and nicotine addiction epidemic through the development and commercialization of cytisinicline as a treatment for nicotine dependence.
Explore Achieve Life Science's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.